BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laugsand EA, Skorpen F, Kaasa S, Sabatowski R, Strasser F, Fayers P, Klepstad P. Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids. Clin Transl Gastroenterol 2015;6:e90. [PMID: 26087058 DOI: 10.1038/ctg.2015.19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed S, Choudhry Z, Bhatti JA. Impact of genetic polymorphisms on opioid misuse: a scoping review. Pharmacogenomics 2019;20:685-703. [DOI: 10.2217/pgs-2018-0180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Klepstad P, Skorpen F. Genetic findings related to pain and analgesics–why are they so inconsistent? Pain 2016;157:284-5. [DOI: 10.1097/j.pain.0000000000000436] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Skorpen F, von Hofacker S, Bjørngaard M, Skogholt AH, Dale O, Kaasa S, Klepstad P. The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses. Acta Anaesthesiol Scand 2016;60:1084-91. [DOI: 10.1111/aas.12739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Oosten AW, Matic M, van Schaik RH, Look MP, Jongen JL, Mathijssen RH, van der Rijt CC. Opioid treatment failure in cancer patients: the role of clinical and genetic factors. Pharmacogenomics 2016;17:1391-403. [PMID: 27472837 DOI: 10.2217/pgs-2016-0082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
5 Chen H, Zhang C, Zhou Q, Guo Y, Ren Z, Yu Z, Del Turco S. Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/5764592] [Reference Citation Analysis]
6 Liu J, Chen X, Jiang Y, Cheng W. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer. International Immunopharmacology 2020;86:106735. [DOI: 10.1016/j.intimp.2020.106735] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Liu A, Wu Q, Peng D, Ares I, Anadón A, Lopez-Torres B, Martínez-Larrañaga MR, Wang X, Martínez MA. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation. Med Res Rev 2020;40:1973-2018. [PMID: 32525219 DOI: 10.1002/med.21696] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A. MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 2020;28:23-33. [DOI: 10.1007/s00520-019-05016-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
9 Kaski SW, Brooks S, Wen S, Haut MW, Siderovski DP, Berry JH, Lander LR, Setola V. Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia. J Opioid Manag 2019;15:103-9. [PMID: 31057342 DOI: 10.5055/jom.2019.0491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Valenta S, Spichiger E, Paul SM, Rabow MW, Plano Clark VL, Schumacher KL, Miaskowski C. A Longitudinal Study of Predictors of Constipation Severity in Oncology Outpatients With Unrelieved Pain. J Pain Symptom Manage 2020;59:9-19.e1. [PMID: 31494176 DOI: 10.1016/j.jpainsymman.2019.08.027] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Yan T, Su J, Zhou L, Zhang L. Polymorphisms of 5-hydroxytryptamine receptor type 3B gene and clinical characteristics for vomiting after breast surgery in chinese han female population. J Clin Pharm Ther 2021;46:936-41. [PMID: 33605481 DOI: 10.1111/jcpt.13386] [Reference Citation Analysis]
12 Matic M, Jongen JL, Elens L, de Wildt SN, Tibboel D, Sillevis Smitt PA, van Schaik RH. Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirement. Pharmacogenomics 2017;18:1133-42. [PMID: 28745577 DOI: 10.2217/pgs-2017-0060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
13 Davies A, Leach C, Butler C, Gregory A, Henshaw S, Minton O, Shorthose K, Batsari KM. Opioid-induced constipation in patients with cancer: a "real-world," multicentre, observational study of diagnostic criteria and clinical features. Pain 2021;162:309-18. [PMID: 32701649 DOI: 10.1097/j.pain.0000000000002024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Gervais C, Ducrotté P, Piche T, Di Palma M, Jovenin N, Scotté F. [Constipation and cancer: Current strategies]. Bull Cancer 2016;103:794-804. [PMID: 27341746 DOI: 10.1016/j.bulcan.2016.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
15 Lee KH, Kim TW, Kang JH, Kim JS, Ahn JS, Kim SY, Yun HJ, Eum YJ, Koh SA, Kim MK, Hong YS, Kim JE, Lee GW. Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial. Chin J Cancer 2017;36:74. [PMID: 28893309 DOI: 10.1186/s40880-017-0241-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]